Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate
A Addetia, KHD Crawford, A Dingens… - Journal of clinical …, 2020 - Am Soc Microbiol
The development of vaccines against SARS-CoV-2 would be greatly facilitated by the
identification of immunological correlates of protection in humans. However, to date, studies …
identification of immunological correlates of protection in humans. However, to date, studies …
Potential antigenic cross-reactivity between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and dengue viruses
Abstract Background Coronavirus disease 2019 (COVID-19) and dengue fever are difficult
to distinguish given shared clinical and laboratory features. Failing to consider COVID-19 …
to distinguish given shared clinical and laboratory features. Failing to consider COVID-19 …
Association between SARS-CoV-2 neutralizing antibodies and commercial serological assays
Abstract Background Commercially available SARS-CoV-2 serological assays based on
different viral antigens have been approved for the qualitative determination of anti-SARS …
different viral antigens have been approved for the qualitative determination of anti-SARS …
Side-by-side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity
T Perkmann, N Perkmann-Nagele, MK Breyer… - Clinical …, 2020 - academic.oup.com
Background In the context of the COVID-19 pandemic, numerous new serological test
systems for the detection of anti-SARS-CoV-2 antibodies rapidly have become available …
systems for the detection of anti-SARS-CoV-2 antibodies rapidly have become available …
[HTML][HTML] Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates
T Liu, J Hsiung, S Zhao, J Kost, D Sreedhar… - Nature biomedical …, 2020 - nature.com
Accurate assays for the detection of antibodies to SARS-CoV-2 (severe acute respiratory
syndrome coronavirus 2) are essential for the control of the COVID-19 (coronavirus disease …
syndrome coronavirus 2) are essential for the control of the COVID-19 (coronavirus disease …
Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests
C Schnurra, N Reiners, R Biemann, T Kaiser… - Journal of Clinical …, 2020 - Elsevier
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) has
been followed by the rapid development of antibody tests. To assess the utility of the tests for …
been followed by the rapid development of antibody tests. To assess the utility of the tests for …
Commercial serology assays predict neutralization activity against SARS-CoV-2
RT Suhandynata, MA Hoffman, D Huang… - Clinical …, 2021 - academic.oup.com
Background It is unknown whether a positive serology result correlates with protective
immunity against SARS-CoV-2. There are also concerns regarding the low positive …
immunity against SARS-CoV-2. There are also concerns regarding the low positive …
Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain
Nucleocapsid (N) encoded by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) plays key roles in the replication cycle and is a critical serological marker. Here, we …
2) plays key roles in the replication cycle and is a critical serological marker. Here, we …
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody
MA Trabaud, V Icard, MP Milon, A Bal, B Lina… - Journal of Clinical …, 2020 - Elsevier
Background Many commercial assays, of different designs, detecting SARS-CoV-2-specific
antibodies exist but with little experience with them. Objectives The aim of this study was to …
antibodies exist but with little experience with them. Objectives The aim of this study was to …
Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples
V Haselmann, M Kittel, C Gerhards, M Thiaucourt… - Clinica chimica acta, 2020 - Elsevier
Background For epidemiologic, social and economic reasons, assessment of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection prevalence and immunity are …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection prevalence and immunity are …